Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harmjan Kuipers

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
NPJ Vaccines|November 11, 2023
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigenMaarten Swart, Harmjan Kuipers, Fin Milder, et al.
NPJ Vaccines|July 7, 2018
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challengeJoan E M van der Lubbe, Jeroen Huizingh, Johan W A Verspuij, et al.
Nature Communications|November 14, 2024
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primatesAneesh Vijayan, Ronald Vogels, Rachel Groppo, et al.
Science (New York, N.Y.)|August 26, 2015
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogenAntonietta Impagliazzo, Fin Milder, Harmjan Kuipers, et al.
NPJ Vaccines|March 17, 2023
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2Maarten Swart, Joan van der Lubbe, Sonja Schmit-Tillemans, et al.
The Journal of Experimental Medicine|April 28, 2021
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHPLaura Solforosi, Harmjan Kuipers, Mandy Jongeneelen, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
NPJ Vaccines|November 11, 2023
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigenMaarten Swart, Harmjan Kuipers, Fin Milder, et al.
NPJ Vaccines|July 7, 2018
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challengeJoan E M van der Lubbe, Jeroen Huizingh, Johan W A Verspuij, et al.
Nature Communications|November 14, 2024
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primatesAneesh Vijayan, Ronald Vogels, Rachel Groppo, et al.
Science (New York, N.Y.)|August 26, 2015
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogenAntonietta Impagliazzo, Fin Milder, Harmjan Kuipers, et al.
NPJ Vaccines|March 17, 2023
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2Maarten Swart, Joan van der Lubbe, Sonja Schmit-Tillemans, et al.
The Journal of Experimental Medicine|April 28, 2021
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHPLaura Solforosi, Harmjan Kuipers, Mandy Jongeneelen, et al.
Pageof 3